Liu Liang, Zheng Feng
Department of Thoracic Surgery, The TCM Hospital of Changzhou Affiliated to Nanjing University of TCM, Changzhou, Jiangsu, People's Republic of China.
Department of Critical Care Medicine, The Third Affiliated Hospital of Soochow University, The First People's Hospital of Changzhou, Changzhou, Jiangsu, People's Republic of China.
Onco Targets Ther. 2016 Oct 7;9:6083-6091. doi: 10.2147/OTT.S118481. eCollection 2016.
Numerous studies have examined the association between interleukin-10 (, and -) gene polymorphisms and risk of lung cancer, but these have revealed inconsistent results. The aim of this study was to clarify the relationship between these polymorphisms and the risk of lung cancer by performing a meta-analysis. The published literature concerning IL-10 polymorphisms and lung cancer risk were retrieved by systematically searching PubMed, Embase, Web of Science, China National Knowledge Infrastructure, WanFang, and Database of Chinese Scientific and Technical Periodicals (VIP) database. Statistical analysis was conducted with Stata 12.0 software. A total of ten published articles comprising of 19 studies were selected, including seven studies (1,960 controls and 1,321 cases) for , seven studies (2,613 controls and 1,839 cases) for , and five studies (1,558 controls and 926 cases) for . This study found that the and - polymorphisms were significantly associated with the risk of lung cancer in the overall analysis. When stratified by ethnicity, significantly increased risks were observed for , and - polymorphisms in Asians (for -1082A/G, AA vs [AG + GG]: odds ratio [OR] =1.20, confidence interval [CI] =1.05-1.39, <0.05; for C-592A, C vs A, OR =1.36, CI =1.20-1.53, <0.05; CC vs AA, OR =1.85, CI =1.45-2.37, <0.05; CC vs [CA + AA], OR =1.36, CI =1.15-1.61, <0.05; for -, T vs C: OR =1.21, CI =1.06-1.38, <0.05; TT vs CC, OR =1.54, CI =1.18-2.01, <0.05; [TT + TC] vs CC, OR =1.51, CI =1.17-1.95, <0.05). Moreover, the data indicated that there was a significant association between polymorphism and non-small-cell lung cancer risk. No significant publication bias was detected under the four genetic models (allele model, homozygous model, dominant model, and recessive model) in this meta-analysis. On the basis of these 19 studies, this study found that the and - polymorphisms might have a significant association with risk of lung cancer in Asian populations.
众多研究探讨了白细胞介素-10(IL-10)基因多态性与肺癌风险之间的关联,但结果并不一致。本研究旨在通过荟萃分析阐明这些多态性与肺癌风险之间的关系。通过系统检索PubMed、Embase、Web of Science、中国知网、万方和维普数据库,获取有关IL-10基因多态性与肺癌风险的已发表文献。使用Stata 12.0软件进行统计分析。共纳入10篇发表文章,包含19项研究,其中针对IL-10 -1082A/G多态性的研究有7项(1960例对照和1321例病例),针对IL-10 C-592A多态性的研究有7项(2613例对照和1839例病例),针对IL-10 -819C/T多态性的研究有5项(1558例对照和926例病例)。本研究发现,在总体分析中,IL-10 -1082A/G、C-592A和 -819C/T多态性与肺癌风险显著相关。按种族分层时,亚洲人中IL-10 -1082A/G、C-592A和 -819C/T多态性的风险显著增加(对于 -1082A/G,AA与[AG + GG]相比:比值比[OR]=1.20,置信区间[CI]=1.05 - 1.39,P<0.05;对于C-592A,C与A相比,OR =1.36,CI =1.20 - 1.53,P<0.05;CC与AA相比,OR =1.85,CI =1.45 - 2.37,P<0.05;CC与[CA + AA]相比,OR =1.36,CI =1.15 - 1.61,P<0.05;对于 -819C/T,T与C相比:OR =1.21,CI =1.06 - 1.38,P<0.05;TT与CC相比,OR =1.54,CI =1.18 - 2.01,P<0.